Examination of efficacy of yokukansan for post operative delirium

Examination of efficacy of yokukansan for post operative delirium - Examination of efficacy of yokukansan for post operative delirium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027475

Enrollment

100

Registered

2017-08-20

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative delirium

Interventions

yokukansan administering group(7.5mg/day) yokukansan non-administering group(0mg/day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients undergoing elective surgery for gastrointestinal cancer 2)Patients aged over 70 3)Patients who give written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1)patients who require emergency surgery 2)Patients with severe complications , including cardiac , renal , blood , lung or liver diseases , or , with other complications judged to be life-theatening 3)Serious complications due to psychological illness 4)Other Kampo medicine 5)patients who were judged to be inappropriate as subjects by the study investigators

Design outcomes

Primary

Measure	Time frame
The incidence of post operative delirium	—

Secondary

Measure	Time frame
Hospital days after the operation Severity of symptoms of delirium	—

Countries

Japan

Contacts

Public ContactSatoshi Kanda

Juntendo University Gatoroenterology and Minimally invasive surgery

sat-kanda@rapid.ocn.ne.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026